Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Cardinal Health (CAH) PT Raised to $119 at Deutsche Bank
August 15, 2024 1:41 PM EDTDeutsche Bank analyst George Hill raised the price target on Cardinal Health (NYSE: CAH) to $119.00 (from $115.00) while maintaining a Hold rating.
The analyst comments "FQ4 Earnings Beat and A Raise on FY25 Outlook: CAH reported F4Q results and raised its FY25 outlook and now sees full year EPS of $7.55 - $7.70 vs prior guidance of >$7.50 and the Streets estimate of $7.53. Within the additional 5-20c of EPS guide up, approximately 11c are attributed to lower interest expenses plus share... More
Cardinal Health (CAH) Tops Q4 EPS by 11c, Beats on Revenue; Offers FY25 EPS Guidance
August 14, 2024 6:31 AM EDTCardinal Health (NYSE: CAH) reported Q4 EPS of $1.84, $0.11 better than the analyst estimate of $1.73. Revenue for the quarter came in at $59.9 billion versus the consensus estimate of $58.64 billion.
GUIDANCE:
Cardinal Health sees FY2025 EPS of $7.55-$7.70, versus the consensus of... More
